fda semaglutide news approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/ news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults fda compounding semaglutide warning letter

Many patients can lose a substantial amount of weight often 10% or more of their body weight in a year which can improve diabetes control and other health markers

EGT was also demonstrated to play no role in protecting mycelia from cupric oxide toxicity

Ongoing research is probing novel applications of GLP-1 agonists beyond diabetes and obesity from potential use in metabolic dysfunction-associated steatohepatitis (MASH) to trials investigating neuroprotective effects in conditions like Parkinsons and Alzheimers disease, though the 2025 phase 3 trials in both conditions failed to show clinical benefit ( [24] ) ( [25] )

Randomized trials of low-FODMAP diets show significantly greater improvements in global IBS symptoms compared with standard dietary advice.68 Choosing lower-lactose or lactose-free dairy (such as lactose-free milk, yogurt, and hard cheeses) can be more effective and easier to sustain than taking lactase with every meal for some people with lactose intolerance

What are the possible complications of carnitine deficiency

But now Mark's main focus is, I asked him if he was going to write another book